Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis
<i>Background and Objectives</i>: Recently, a randomized controlled trial suggested a potential benefit of baricitinib in patients with diabetes mellitus, preserving β-cell function. However, the clinical evidence currently available is limited. We aimed to assess the potential impact of tofacitinib...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2024-02-01
|
| Colecção: | Medicina |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/1648-9144/60/3/360 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|